Literature DB >> 9307013

Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.

A Ben Nasr1, H Herwald, U Sjöbring, T Renné, W Müller-Esterl, L Björck.   

Abstract

H-kininogen (high-molecular-mass kininogen, HK) is the precursor of the vasoactive peptide hormone bradykinin (BK). Previous work has demonstrated that HK binds to Streptococcus pyogenes through M-proteins, fibrous surface proteins and important virulence factors of these bacteria. Here we find that M-protein-expressing bacteria absorb HK from human plasma. The HK bound to the bacteria was found to be cleaved, and analysis of the degradation pattern suggested that the cleavage of HK at the bacterial surface is associated with the release of BK. Moreover, addition of activated plasma prekallikrein to bacteria preincubated with human plasma, resulted in BK release. This mechanism, by which a potent vasoactive and proinflammatory peptide is generated at the site of infection, should influence the host-parasite relationship during S. pyogenes infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307013      PMCID: PMC1218718     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Human kininogens.

Authors:  W Müller-Esterl; D A Johnson; G Salvesen; A J Barrett
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Prekallikrein.

Authors:  M Silverberg; A P Kaplan
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.

Authors:  D M Neville
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

Review 5.  The contact system and sepsis.

Authors:  R W Colman
Journal:  Prog Clin Biol Res       Date:  1994

6.  Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli.

Authors:  A Ben Nasr; A Olsén; U Sjöbring; W Müller-Esterl; L Björck
Journal:  Mol Microbiol       Date:  1996-06       Impact factor: 3.501

7.  Isolation and functional properties of the heavy and light chains of human plasma kallikrein.

Authors:  F van der Graaf; G Tans; B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

8.  Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.

Authors:  A Molla; T Yamamoto; T Akaike; S Miyoshi; H Maeda
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

9.  Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.

Authors:  D Burger; W D Schleuning; M Schapira
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

10.  Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli.

Authors:  A Olsén; A Jonsson; S Normark
Journal:  Nature       Date:  1989-04-20       Impact factor: 49.962

View more
  17 in total

1.  Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system.

Authors:  Sara H Bengtson; Caroline Sandén; Matthias Mörgelin; Pauline F Marx; Anders I Olin; L M Fredrik Leeb-Lundberg; Joost C M Meijers; Heiko Herwald
Journal:  J Innate Immun       Date:  2008-07-12       Impact factor: 7.349

2.  Adsorption of components of the plasma kinin-forming system on the surface of Porphyromonas gingivalis involves gingipains as the major docking platforms.

Authors:  Maria Rapala-Kozik; Grazyna Bras; Barbara Chruscicka; Justyna Karkowska-Kuleta; Aneta Sroka; Heiko Herwald; Ky-Anh Nguyen; Sigrun Eick; Jan Potempa; Andrzej Kozik
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemièrre's syndrome.

Authors:  Karin Holm; Inga-Maria Frick; Lars Björck; Magnus Rasmussen
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 4.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

5.  Streptococcus pyogenes triggers activation of the human contact system by streptokinase.

Authors:  Ramona Nitzsche; Maik Rosenheinrich; Bernd Kreikemeyer; Sonja Oehmcke-Hecht
Journal:  Infect Immun       Date:  2015-08       Impact factor: 3.441

6.  Staphylococcus aureus induces release of bradykinin in human plasma.

Authors:  E Mattsson; H Herwald; H Cramer; K Persson; U Sjöbring; L Björck
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 7.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system.

Authors:  K Persson; M Mörgelin; L Lindbom; P Alm; L Björck; H Herwald
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

Review 10.  Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.

Authors:  Sarbani Bhattacharya; Victoria A Ploplis; Francis J Castellino
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.